Research Study for those with Mild to Moderate Dementia with Lewy Bodies

UVA Tracking #
HSR220099
Principal Investigator
Anelyssa D'Abreu
Contact
Colleen Webber
Contact Email
Contact Phone
434.243.5898
Official Trial Title
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2, 6-MONTH STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND EXPLORATORY EFFICACY OF CT1812 IN SUBJECTS WITH MILD TO MODERATE DEMENTIA WITH LEWY BODIES
Study Description

The Neurology Department seeks adults ages 50 to 85 with Mild to Moderate Dementia with Lewy Bodies for a research study. The purpose of the study is to test the safety, tolerability, and effectiveness of an investigational medicine.

You may be eligible for this study if You:
-Have a diagnosis of Mild to Moderate Dementia with Lewy Bodies
-Have a study partner who agrees to participate
-Are in good general health with stable medications

Participation involves taking daily capsules of an investigational medication/placebo, cognitive testing, an MRI scan if you haven’t had one recently, electrocardiograms, blood draws and a lumbar puncture at the beginning and end of the trial. The study consists of a 210 day study period, and 12 study site visits.

All study-related procedures provided at no cost.

You will receive compensation up to $75.00 for each successfully completed study visit.

Compensation

up to $75.00 for each successfully completed study visit